Impacto da obesidade sarcopênica na mortalidade e no início da terapia dialítica em pacientes com doença renal crônica
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
Abstract
The concomitant occurrence of obesity and sarcopenia has been attracting the
attention of researchers around the world in different populations, and in chronic
kidney disease it is no different. Associated with the great concern that, concurrently
with senescence, there is an increase in visceral fat and a reduction in skeletal muscle
mass, triggering a series of harmful health consequences associated with
pathophysiological changes, there is no consensus in the literature on the diagnosis
or treatment of sarcopenic obesity in patients with chronic kidney disease. In this
sense, the present study sought to evaluate the impact of sarcopenic obesity on predialysis chronic kidney disease on the outcomes of death and renal replacement
therapy. After analyzing the data obtained in the sample, it was possible to verify a
high incidence of mortality among the studied population (39% of the sample).
Analyzing the dichotomized sample in individuals with and without sarcopenic obesity,
it was also possible to verify a difference in the lipid profile, in the VLDL (p= 0.043) and
Glucose (p= 0.045) variables. Through the treatment and robust analysis of the data
excluding possible confounders, a direct association between the progression of
chronic kidney disease and low skeletal muscle strength of the evaluated patients
became evident, p= 0.003 for death and p= 0.029 for referral to renal replacement
therapy.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

